Rutgers University, Piscataway, New Jersey 08854
Piscataway, New Jersey, 08854, United States
Location status: Recruiting
NCT Number: NCT07217522
The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Piscataway, New Jersey, 08854, United States
Location status: Recruiting
This is an online research study to learn more about how genes affect the risk of pulmonary hypertension. No office visit is required and in return, participants may receive information about their genetic ancestry for free. Population-based echocardiography surveys show that pulmonary hypertension (PH) affects roughly 2-3 % of community-dwelling adults and becomes more common with age. This study will increase our understanding of the genetic basis of breast cancer, which is a crucial step in drug development to improve current treatment options. The study investigators seek a diverse population because diversity among participants maximizes the usefulness of the data. Participants will use our online study portal to answer questions about their health and provide their DNA via a saliva sample using a pre-paid mailer. Participation takes approximately 20 minutes. Participants will be invited to share data from their electronic health records, but this is not required for study participation. The study investigators keep participants engaged with short monthly newsletters.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Saliva sample is sent via prepaid US Mail for DNA extraction
Health surveys are filled out online in the study portal.
Time frame: 2 years
Genetic factors will be measured through whole exome sequencing along with genotyping of common variants, and then correlated with pulmonary hypertension and pulmonary hypertension subtype.
Contact information is provided by the study sponsor or research team.
Steve Buyske, Ph.D.
CONTACT
Tara Matise, Ph.D.
CONTACT
Rutgers, The State University of New Jersey
Other
Acronym: RUGCC-PH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07667673
Cardiovascular Diseases, Hypertension
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07120789
Adherence Interventions, Behavior
São Paulo, Brazil
View Trial DetailsNCT06351345
Cardiovascular Diseases, Hypertension
Durham, North Carolina, United States
View Trial DetailsNCT04071327
Cardiovascular Diseases, Chronic Thromboembolic Pulmonary Hypertension
Phoenix, Arizona, United States
View Trial Details